172 related articles for article (PubMed ID: 25144649)
1. Intralipid decreases apolipoprotein M levels and insulin sensitivity in rats.
Zheng L; Feng Y; Shi Y; Zhang J; Mu Q; Qin L; Berggren-Söderlund M; Nilsson-Ehle P; Zhang X; Luo G; Xu N
PLoS One; 2014; 9(8):e105681. PubMed ID: 25144649
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein M overexpression through adeno-associated virus gene transfer improves insulin secretion and insulin sensitivity in Goto-Kakizaki rats.
Yu Y; Zhang J; Yao S; Pan L; Luo G; Xu N
J Diabetes Investig; 2020 Sep; 11(5):1150-1158. PubMed ID: 32243104
[TBL] [Abstract][Full Text] [Related]
3. Palmitic acid suppresses apolipoprotein M gene expression via the pathway of PPARβ/δ in HepG2 cells.
Luo G; Shi Y; Zhang J; Mu Q; Qin L; Zheng L; Feng Y; Berggren-Söderlund M; Nilsson-Ehle P; Zhang X; Xu N
Biochem Biophys Res Commun; 2014 Feb; 445(1):203-7. PubMed ID: 24508264
[TBL] [Abstract][Full Text] [Related]
4. [Reduced expression and secretion of apolipoprotein M in fat-fed, streptozotocin-diabetic rats is partially reversed by an artificial ligand of PPARγ].
Qu X; Zhao S; Gao J; Hu M; Dong L; Zhang X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 37(8):796-801. PubMed ID: 22954914
[TBL] [Abstract][Full Text] [Related]
5. Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein.
Liu M; Seo J; Allegood J; Bi X; Zhu X; Boudyguina E; Gebre AK; Avni D; Shah D; Sorci-Thomas MG; Thomas MJ; Shelness GS; Spiegel S; Parks JS
J Biol Chem; 2014 Jan; 289(5):2801-14. PubMed ID: 24318881
[TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone enhances apolipoprotein M (Apom) expression in rat's liver.
Luo G; Feng Y; Zhang J; Mu Q; Shi Y; Qin L; Zheng L; Berggren-Söderlund M; Nilsson-Ehle P; Zhang X; Xu N
Int J Med Sci; 2014; 11(10):1015-21. PubMed ID: 25136257
[TBL] [Abstract][Full Text] [Related]
7. Hyperglycemia-induced downregulation of apolipoprotein M expression is not via the hexosamine pathway.
Jiang B; Zhang X; Di D; Luo G; Shi Y; Zhang J; Berggren-Söderlund M; Nilsson-Ehle P; Xu N
Lipids Health Dis; 2015 Sep; 14():110. PubMed ID: 26377577
[TBL] [Abstract][Full Text] [Related]
8. Hyperglycemia down-regulates apolipoprotein M expression in vivo and in vitro.
Zhang X; Jiang B; Luo G; Nilsson-Ehle P; Xu N
Biochim Biophys Acta; 2007 Jul; 1771(7):879-82. PubMed ID: 17556016
[TBL] [Abstract][Full Text] [Related]
9. Dihydrotestosterone regulating apolipoprotein M expression mediates via protein kinase C in HepG2 cells.
Yi-zhou Y; Bing C; Ming-qiu L; Wei W; Ru-xing W; Jun R; Liu-yan W; Zhao-hui J; Yong J; Guo qing J; Jian Z
Lipids Health Dis; 2012 Dec; 11():168. PubMed ID: 23216709
[TBL] [Abstract][Full Text] [Related]
10. Induction of insulin secretion by apolipoprotein M, a carrier for sphingosine 1-phosphate.
Kurano M; Hara M; Tsuneyama K; Sakoda H; Shimizu T; Tsukamoto K; Ikeda H; Yatomi Y
Biochim Biophys Acta; 2014 Sep; 1841(9):1217-26. PubMed ID: 24814049
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of apolipoprotein M expression is mediated by phosphatidylinositol 3-kinase in HepG2 cells.
Xu N; Ahrén B; Jiang J; Nilsson-Ehle P
Biochim Biophys Acta; 2006 Feb; 1761(2):256-60. PubMed ID: 16542871
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta down-regulates apolipoprotein M in HepG2 cells.
Xu N; Hurtig M; Zhang XY; Ye Q; Nilsson-Ehle P
Biochim Biophys Acta; 2004 Jul; 1683(1-3):33-7. PubMed ID: 15238217
[TBL] [Abstract][Full Text] [Related]
13. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M.
Christoffersen C; Obinata H; Kumaraswamy SB; Galvani S; Ahnström J; Sevvana M; Egerer-Sieber C; Muller YA; Hla T; Nielsen LB; Dahlbäck B
Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9613-8. PubMed ID: 21606363
[TBL] [Abstract][Full Text] [Related]
14. The association between apolipoprotein M and insulin resistance varies with country of birth.
Memon AA; Bennet L; Zöller B; Wang X; Palmér K; Dahlbäck B; Sundquist J; Sundquist K
Nutr Metab Cardiovasc Dis; 2014 Nov; 24(11):1174-80. PubMed ID: 24984825
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein M: Research progress, regulation and metabolic functions (Review).
Huang LZ; Gao JL; Pu C; Zhang PH; Wang LZ; Feng G; Zhang Y
Mol Med Rep; 2015 Aug; 12(2):1617-24. PubMed ID: 25901639
[TBL] [Abstract][Full Text] [Related]
16. TGF-β Down-regulates Apolipoprotein M Expression through the TAK-1-JNK-c-Jun Pathway in HepG2 Cells.
Ren K; Mo ZC; Liu X; Tang ZL; Jiang Y; Peng XS; Zhang QH; Shi JF; Yi GH
Lipids; 2017 Feb; 52(2):109-117. PubMed ID: 28039587
[TBL] [Abstract][Full Text] [Related]
17. Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M.
Kurano M; Tsukamoto K; Ohkawa R; Hara M; Iino J; Kageyama Y; Ikeda H; Yatomi Y
Atherosclerosis; 2013 Jul; 229(1):102-9. PubMed ID: 23664237
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine 1-phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons.
Frej C; Linder A; Happonen KE; Taylor FB; Lupu F; Dahlbäck B
J Cell Mol Med; 2016 Jun; 20(6):1170-81. PubMed ID: 26990127
[TBL] [Abstract][Full Text] [Related]
19. [Effects of fenofibrate on the expression of peroxisome proliferator-activated-gamma coactivator-1α in skeletal muscle of rats infused with intralipid].
Bai XP; Li HL; Yang WY; Xiao JZ; Wang B
Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(40):2856-9. PubMed ID: 21162799
[TBL] [Abstract][Full Text] [Related]
20. Foxa2 activity increases plasma high density lipoprotein levels by regulating apolipoprotein M.
Wolfrum C; Howell JJ; Ndungo E; Stoffel M
J Biol Chem; 2008 Jun; 283(24):16940-9. PubMed ID: 18381283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
